Skip to main content

Advertisement

SpringerLink
Log in

Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity)

  • Review
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Ocular tuberculosis is difficult to diagnose but should be suspected when uveitis fails to respond to inflammation suppressive therapy. Interferon-gamma release assays (IGRAs) represent a substantial help to diagnose suspected ocular tuberculosis especially in non-endemic areas. Indocyanine green angiography (ICGA) is able to detect clinically silent choroiditis that, when associated with a positive IGRA test, should lead the clinician to suspect ocular tuberculosis, warranting specific therapy. The fact that IGRA tests can also react with some atypical strains of mycobacteria is not always known. We report here a case with resistant post-operative inflammation that presented with occult ICGA-detected choroiditis and a positive IGRA test that was most probably due to the non-tuberculous mycobacterium (NTM) Mycobacterium kansasii. A 66 year-old man presented with a resistant cystoid macular oedema (CMO) in his left eye after combined cataract and epiretinal membrane surgery. At entry, his best-corrected visual acuity (BCVA) was 0.5 for far and near OS. Intraocular inflammation measured by laser flare photometry was elevated in the left eye (54.4 ph/ms) and also in the right eye (50.9 ph/ms). Four subTenon’s injections of 40 mg of triamcinolone did not produce any substantial improvement. Therefore a complete uveitis work-up was performed. Fluorescein angiography showed CMO OS and ICGA showed numerous hypofluorescent dots and fuzziness of choroidal vessels in both eyes. Among performed laboratory tests, the QuantiFERON®-TB Gold test was positive. After a pulmonological examination disclosing a right upper lobe infiltrate, the patient was started on a triple anti-tuberculous therapy. Bronchial aspirate, obtained during bronchoscopy, was Ziehl-positive and culture grew M. kansasii. Nine months later, BCVA OS increased to 1.0 and flare decreased to 40.2 ph/ms. The CMO OS resolved angiographically and did not recur with a macula still slightly thickened on OCT. Suspected ocular tuberculosis based on clinical findings and a positive IGRA test can, in rare instances, be due to atypical mycobacteria that also produce positive IGRA tests such as M. kansasii, M. szulgai, M. gordonae, M. flavescens and M. marinum. In our case failure to isolate the atypical mycobacterium would not have had negative therapeutic consequences, as M. kansasii is sensitive to the standard anti-tuberculous treatments, which is not the case with other NTMs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Abu El-Asrar A, Al-Mezaine HS (2010) Anti-tuberculous therapy combined with systemic corticosteroids improves retinal sensitivity in patients with active presumed tuberculous choroiditis. Int Ophthalmol 30:567–576

    Article  PubMed  Google Scholar 

  2. Bouchenaki N, Herbort CP (2011) Indocyanine green angiography guided management of Vogt-Koyanagi-Harada disease. J Ophthalmic Vis Res 6:241–248

    PubMed  CAS  Google Scholar 

  3. Papadia M, Herbort CP (2011) Unilateral papillitis, the tip of the iceberg of bilateral ICGA-detected tuberculous choroiditis. Ocul Immunol Inflamm 19:124–126

    Article  PubMed  Google Scholar 

  4. De Luigi G, Mantovani A, Papadia M, Herbort CP (2012) Tuberculous-related choriocapillaris (multifocal-serpiginous choroiditis): follow-up and precise monitoring of therapy by indocyanine green angiography. Int Ophthalmol 17 (Epub Ahead of Print)

  5. Lalvani A (2007) Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 131:1898–1906

    Article  PubMed  Google Scholar 

  6. Lalvani A, Pareek M (2010) Interferon gamma release assays: principles and practice. Enferm Infecc Microbiol Clin 28:245–252

    Article  PubMed  Google Scholar 

  7. Vordermeier HM, Brown J, Cockle PJ, Franken WPJ, Arend SM, Ottenhoff THM, Jahans K, Hewinson RG (2007) Assessment of cross-reactivity between Mycobacterium bovis and M. kansasii ESAT-6 and CFP-10 at the T-cell epitope level. Clin Vaccine Immunol 14:1203–1209

    Article  PubMed  CAS  Google Scholar 

  8. Ingen J, Zwaan R, Dekhuijzen R, Boeree M, Soolingen D (2009) Region of difference 1 in nontuberculous mycobacterium species adds a phylogenetic and taxonomical character. J Bacteriol 191:5865–5867

    Article  PubMed  Google Scholar 

  9. Sinawat S, Yospaiboon Y, Sinawat S (2011) Bilateral endogenous endophthalmitis in disseminated NTM infection: a case report. J Med Assoc Thai 94:632–636

    PubMed  Google Scholar 

  10. Lai LL, Chen SN, Kuo YH, Ho JD, Ho CL (2002) Presumed choroidal atypical tuberculosis superinfected with cytomegalovirus retinitis in an acquired immunodeficiency syndrome patient: a case report. Jpn J Ophthalmol 46:463–468

    Article  PubMed  Google Scholar 

  11. Grenzebach UH, Busse H, Tötsch M, Dockhorn-Dworniczak B (1996) Endophthalmitis induced by atypical mycobacterial infection. Ger J Ophthalmol 5:202–206

    PubMed  CAS  Google Scholar 

  12. Tanemoto K, Ishikawa H, Kigasawa K, Obazawa H, Fusegawa H, Miyachi H, Ando Y (1997) Detection of mycobacterial DNA with polymerase chain reaction in eye discharge and gastric juices in a case of scleritis. Nihon Ganka Gakkai Zasshi 101:97–101

    PubMed  CAS  Google Scholar 

  13. Gineys R, Bodaghi B, Carcelain G, Cassoux N, le Boutin TH, Amoura Z, Lehoang P, Trad S (2011) QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation. Am J Ophthalmol 152:433–440

    PubMed  Google Scholar 

  14. Bansal R, Gupta A, Gupta V, Dogra MR, Bambery P, Arora SK (2008) Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis. Am J Ophthalmol 146:772–779

    Article  PubMed  CAS  Google Scholar 

  15. Jarzembowski JA, Young MB (2008) Nontuberculous mycobacterial infections. Arch Pathol Lab Med 132:1333–1341

    PubMed  Google Scholar 

  16. Freitas D, Alvarenga L, Sampaio J, Mannis M, Sato E, Sousa L, Vieira L, Yu MC, Martins MC, Hoffling-Lima A, Belfort R Jr (2003) An outbreak of Mycobacterium chelonae infection after LASIK. Ophthalmology 110:276–285

    Article  PubMed  Google Scholar 

  17. Brown-Elliott BA, Mann LB, Hail D, Whitney C, Wallace RJ Jr. (2012) Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections. Cornea [Epub Ahead of Print]

  18. Girgis DO, Karp CL, Miller D (2011) Ocular infections due to nontuberculous mycobacteria: update on epidemiology and management. Clin Experiment Ophthalmol [Epub Ahead of Print]

  19. Shen GH, Chiou CS, Hu ST, Wu KM, Chen JH (2011) Rapid identification of the Mycobacterium tuberculosis complex by combining the ESAT-6/CFP-10 immunochromatographic assay and smear morphology. J Clin Microbiol 49:902–907 Epub 2010 Dec 15

    Article  PubMed  CAS  Google Scholar 

  20. Kaur P, Fishman JA, Misdraji J, Varma MC, Kotton CN (2011) Disseminated Mycobacterium kansasii infection with hepatic abscesses in a renal transplant recipient. Transpl Infect Dis 13:531–535

    Article  PubMed  CAS  Google Scholar 

  21. Shitrit D, Baum GL, Priess R, Lavy A, Shitrit AB-G, Raz M, Shlomi D, Daniele B, Kramer MR (2006) Pulmonary Mycobacterium kansasii infection in Israel, 1999–2004: clinical features, drug susceptibility, and outcome. Chest 129:771–776

    Article  PubMed  Google Scholar 

  22. Schonherr U, Naumann GOH, Lang GK, Bialasiewicz AA (1989) Sclerokeratitis caused by Mycobacterium marinum [letter]. Am J Ophthalmol 108:607–608

    PubMed  CAS  Google Scholar 

  23. David DB, Hirst LW, McMillen J, Whitby M (1999) Mycobacterium marinum keratitis: pigmentation a clue to diagnosis. Eye (London) 13:377–379

    Article  Google Scholar 

  24. Benton J, Karkanevatos A (2007) Preseptal cellulitis due to Mycobacterium marinum. J Laryngol Otol 121(6):606–608

    Article  PubMed  CAS  Google Scholar 

  25. Frueh BE, Dubuis O, Imesch P, Böhnke M, Bodmer T (2000) Mycobacterium szulgai keratitis. Arch Ophthalmol 118:1123–1124

    PubMed  CAS  Google Scholar 

  26. Telahun A, Waring GO, Grossniklaus HE (1992) Mycobacterium gordonae keratitis. Cornea 11:77–82

    Article  PubMed  CAS  Google Scholar 

  27. Moore MB, Newton C, Kaufman HE (1986) Chronic keratitis caused by Mycobacterium gordonae. Am J Ophthalmol 102:516–521

    PubMed  CAS  Google Scholar 

  28. Bullington RH Jr, Lanier JD, Font RL (1992) Nontuberculous mycobacterial keratitis. Report of two cases and review of the literature. Arch Ophthalmol 110:519–524

    Article  PubMed  Google Scholar 

  29. Rastogi N, Goh KS, Guillou N, Labrousse V (1992) Spectrum of drugs against atypical mycobacteria: how valid is the current practice of drug susceptibility testing and the choice of drugs? Zentralbl Bakteriol 277:474–484

    Article  PubMed  CAS  Google Scholar 

  30. Santin M, Dorca J, Alcaide F, Gonzalez L, Casas S, Lopez M, Guerra MR (2009) Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease. Eur Respir J 33:148–152

    Article  PubMed  CAS  Google Scholar 

  31. Falkinham JO (1996) Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 9:177–215

    PubMed  Google Scholar 

  32. Wang HX, Yue J, Han M, Yang JH, Gao RL, Jing LJ, Yang SS, Zhao YL (2010) Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008. Chin Med J (Engl) 123:184–187

    Google Scholar 

  33. Dautzenberg B, Truffot C, Mignon A, Rozenbaum W, Katlama C, Perronne C, Parrot R, Grosset J (1991) Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Groupe d’Etude et de Traitement des Infections à Mycobacteries Résistantes. Tubercle 72:168–175

    Article  PubMed  CAS  Google Scholar 

  34. Katoch VM (2004) Infections due to non-tuberculous mycobacteria (NTM). Indian J Med Res 120:290–304

    PubMed  CAS  Google Scholar 

  35. Tomiyama Y, Maesaki S, Yong B, Higashiyama Y, Miyazaki Y, Tomono K, Tashiro T, Kohno S (1999) The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection. Kekkaku 74:457–461

    PubMed  CAS  Google Scholar 

  36. Asija A, Prasad A, Eskridge E (2011) Disseminated Mycobacterium gordonae infection in an immunocompetent host. Am J Ther 18:e75–e77

    Article  PubMed  Google Scholar 

  37. Giaconi J, Pham R, Ta CN (2002) Bilateral Mycobacterium abscessus keratitis after laser in situ keratomileusis. J Cataract Refract Surg 28:887–890

    Article  PubMed  Google Scholar 

  38. El-Asrar AM, Tabbara KF (1995) Chronic endophthalmitis after extracapsular cataract extraction caused by Mycobacterium chelonae subspecies abscessus. Eye 9:798–801

    Article  PubMed  Google Scholar 

  39. Marin-Casanova P, Calandria Amiguetti JL, Garcia-Martos P, Lozano DC, Sanabria BH, Puerto Alonso JL et al (2003) Endophthalmitis caused by Mycobacterium abscessus. Eur J Ophthalmol 13:800–802

    PubMed  CAS  Google Scholar 

  40. Benz MS, Murray TG, Dubovy SR, Katz RS, Eifrig CW (2003) Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol 121:271–273

    Article  PubMed  Google Scholar 

  41. Ford JG, Huang AJ, Pflugfelder SC, Alfonso EC, Forster RK, Miller D (1998) Nontuberculous mycobacterial keratitis in south Florida. Ophthalmology 105:1652–1658

    Article  PubMed  CAS  Google Scholar 

  42. Knapp A, Stern GA, Hood CI (1987) Mycobacterium avium-intracellulare corneal ulcer. Cornea 6:175–180

    Article  PubMed  CAS  Google Scholar 

  43. Turner L, Stinson I (1965) Mycobacterium fortuitum as a cause of corneal ulcer. Am J Ophthalmol 60:329–331

    PubMed  CAS  Google Scholar 

  44. Smith RE, Salz JJ, Moors R, Silverstein D, Lewis W (1980) Mycobacterium chelonei and orbital granuloma after tear duct probing. Am J Ophthalmol 89:139–141

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Retinal and Inflammatory Diseases, Centre for Ophthalmic Specialised Care (COS), Rue de la Grotte 6, 1003, Lausanne, Switzerland

    Tatiana I. Kuznetcova & Carl P. Herbort

  2. Department of Ophthalmology, I.P. Pavlov State Medical University, Saint-Petersburg, Russia

    Tatiana I. Kuznetcova

  3. Pulmonology and Immunology Consultations, Morges Hospital, Morges, Switzerland

    Alain Sauty

  4. University of Lausanne, Lausanne, Switzerland

    Alain Sauty & Carl P. Herbort

Authors
  1. Tatiana I. Kuznetcova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alain Sauty
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carl P. Herbort
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carl P. Herbort.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuznetcova, T.I., Sauty, A. & Herbort, C.P. Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity). Int Ophthalmol 32, 499–506 (2012). https://doi.org/10.1007/s10792-012-9588-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-012-9588-3

Keywords

Search

Navigation